Prediction of tissue origin of adenocarcinomas in the esophagogastric junction by DNA methylation-Reference-Cited by-同舟云学术

Prediction of tissue origin of adenocarcinomas in the esophagogastric junction by DNA methylation

Published:2021-09-23 Issue: Volume: Page:
ISSN:1436-3291
Container-title:Gastric Cancer
language:en
Short-container-title:Gastric Cancer

Author:

Zhang Chun-Dong,Takeshima Hideyuki,Sekine Shigeki,Yamashita Satoshi,Liu Yu-Yu,Hattori Naoko,Abe Hiroyuki,Yamashita Hiroharu,Fukuda Masahide,Imamura Yu,Ushiku Tetsuo,Katai Hitoshi,Makino Hiroshi,Watanabe Masayuki,Seto Yasuyuki,Ushijima Toshikazu^ORCID

Funder

Japan Agency for Medical Research and Development

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Gastroenterology,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10120-021-01252-y.pdf

Reference43 articles.

1. Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol. 2000;29:645–54.

2. Yamashita H, Seto Y, Sano T, Makuuchi H, Ando N, Sasako M. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma. Gastric Cancer. 2017;20:69–83.

3. Mariette C, Piessen G, Briez N, Gronnier C, Triboulet JP. Oesophagogastric junction adenocarcinoma: which therapeutic approach? Lancet Oncol. 2011;12:296–305.